August 19, 2013
Takeda Pharmaceutical’s anti-obesity drug OBLEAN (cetilistat) and two other products were added to the list of drugs to be reviewed on August 22 by the Pharmaceutical Affairs and Food Sanitation Council's (PAFSC) First Committee on Drugs, an advisory organ to...read more